Skip to content

Effects of remazolam on neuroelectrophysiological and cerebral oxygen monitoring during carotid endarterectomy

Effects of remazolam on neuroelectrophysiological and cerebral oxygen monitoring during carotid endarterectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122343
Enrollment
Unknown
Registered
2026-04-13
Start date
2024-02-26
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate to severe carotid artery stenosis

Interventions

Remimazolam group:Continuous infusion of remimazolam during surgery
Propofol group:Intraoperative continuous infusion of propofol

Sponsors

Hengshui People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients in our hospital who are confirmed by preoperative ultrasound or digital subtraction angiography (DSA) to have severe carotid artery stenosis, and are scheduled for elective carotid endarterectomy (CEA). (CEA surgical indications: symptomatic carotid stenosis of 50%–99%; asymptomatic carotid stenosis of 70%–99%); 2. No gender restriction, aged 35–80 years, BMI <30 kg/m²; 3. American Society of Anesthesiologists (ASA) classification II or III; 4. No severe hypertension or cardiovascular and cerebrovascular diseases; 5. No mental or neurological disorders and no cognitive dysfunction; 6. No liver, kidney, or coagulation function abnormalities.

Exclusion criteria

Exclusion criteria: 1. Patients with abnormal preoperative muscle strength examination, indicating damage to the limb conduction pathway, or those with contraindications to electrophysiological monitoring; 2. Patients allergic to the drugs used in the study; patients who have become addicted to long-term use of sedatives and analgesics; 3. Patients with communication disorders in terms of mental state, language, and hearing; 4. Carotid artery occlusion; 5. Patients who developed new cerebral infarction within 2 weeks before surgery, experienced ischemic stroke within 3 weeks before surgery, or had intracranial hemorrhage within 3 months before surgery; 6. Patients with serial vascular stenosis lesions or coexisting other diseases that may interfere with the results of this study.

Design outcomes

Primary

MeasureTime frame
Motor evoked potentials;Somatosensory Evoked Potentials;

Secondary

MeasureTime frame
Brain oxygen saturation;

Countries

China

Contacts

Public ContactWang Fuchao

Hengshui People's Hospital

wfchhs@163.com+86 180 0318 6120

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026